Combinatorial Chemistry Advanced Medicinal Chemistry (Pharm 5219): Section A Ref.: An Introduction to Medicinal Chemistry, 3 rd ed. 2005, G.L.Patrick,

Slides:



Advertisements
Similar presentations
Chapter 2, Section 2 Combinations of Atoms.
Advertisements

Distributed Drug Discovery William L. Scott Department of Chemistry and Chemical Biology Indiana University Purdue University Indianapolis, Indianapolis.
D9 – Drug Design (HL). D.9.1 Discuss the use of a compound library in drug design  Over the years, molecules of various substances have been isolated.
Drug design.  electronic databases  contain molecules which have been isolated or synthesized and tested by pharmaceutical companies for possible pharmaceutical.
Jun Qiu and Benjamin Cohen Late Phase Chemical Development
ION EXCHANGE CHROMATOGRAPHY PREPARED BY- MD.MARUF HASSAN.
Drug Discovery The use of solid phase combinatorial chemistry and parallel synthesis.
Labelling probes and primers In the cases of Northern and Southern blots probes are pieces of single stranded DNA that are complimentary to the single.
Combinatorial Chemistry
 Used extensively in relation with drug discovery  Principle of Combinatorial Chemistry ◦ Generation of Compound Libraries from Molecular Building blocks.
27.14 The Strategy of Peptide Synthesis
Section 2: Combinations of Atoms
Enzymes in Industry describe how enzymes can be immobilised; explain why immobilised enzymes are used in large-scale production;
F215 control, genomes and environment
Drug Action and Drug Design. Stereoisomers Stereoisomers are isomers with the same molecular formula AND the same structural formula, but a different.
Combinatorial Chemistry and Library Design
AP Biology Chemistry of Carbon Building Blocks of Life.
An Introduction to Medicinal Chemistry 3/e COMBINATORIAL CHEMISTRY
Combinatorial chemistry The basic principles. What is it about? Synthesising a large number of similar compounds in a short period of time. Compounds.
Biotechnology in Medicine Chapter 12.
Combinatorial Chemistry
Daniel Brown. D9.1 Discuss the use of a compound library in drug design. Traditionally, a large collection of related compounds are synthesized individually.
D9 Drug design Compound libraries Combinatorial and parallel chemistry
Drug design.  electronic databases  contain molecules which have been isolated or synthesized and tested by pharmaceutical companies for possible pharmaceutical.
Building Blocks of Life Organic Chemistry.
1 © Patrick An Introduction to Medicinal Chemistry 3/e Chapter 14 COMBINATORIAL CHEMISTRY Part 2: Sections 14.5 – 14.6.
Drug Design Geometrical isomerism Chirality
The Chemistry of Carbon BUILDING BLOCKS OF LIFE Why study Carbon? All life (on our planet) is carbon-based Cells ◦~72% H 2 O ◦~25% carbon compounds ◦Carbohydrates.
Combinatorial Chemistry. Synthesis of many structures (diversity) combinatorial technology, combinatorial library molecular diversity What is Combinatorial.
Drug Action and Design IB Chemistry Option D: Drugs and Medicines.
Molecular diversity and Drug Design Molecular diversity: differences in physical properties that exist in different molecules. (shape, size, polarity,
Introduction Over the last decade, solid phase synthesis and combinatorial chemistry have undergone major evolution. In the early years, the process of.
Solid-Phase Peptide Synthesis: The Merrifield Method.
SOLID PHASE CHEMISTRY.
DEFINITION The automated synthesis of a large number of compounds in a short time period using a defined reaction route and a large variety of reactantsThe.
Title: The growth curve Homework: complete learning package 1214 January 2016.
Chemistry of Carbon Building Blocks of Life Why study Carbon?  All of life is built on carbon  Cells  72% H 2 O  25% carbon compounds  Carbohydrates.
Combinatorial Chemistry
Combinatorial chemistry
Teaching Aids Service by KRRC Information Section.
Drug Design Geometrical isomerism Chirality
Living By Chemistry SECOND EDITION
An Introduction to Medicinal Chemistry 3/e COMBINATORIAL CHEMISTRY
An understanding of chemistry is fundamental to biology.
DRUG DISCOVERY: FINDING A LEAD
Chemical synthesis of Peptide
Introduction of Combinatorial Chemistry
Building Blocks of Life
Building Blocks of Life
Building Blocks of Life
Immobilising Enzymes.
Building Blocks of Life
Building Blocks of Life
2nd Lecture Comb Chem. 5th Year Pharmacy
Building Blocks of Life
Building Blocks of Life
Building Blocks of Life
6.4 Cloning & Biotechnology
Peptides Can Be Synthesized by Automated Solid-Phase Methods
Statistics 2 for Chemical Engineering lecture 5
Building Blocks of Life
Building Blocks of Life
Building Blocks of Life
Building Blocks of Life
Amino acids, Peptides and Proteins By Prof. Dr. Adel M. Awadallah
Building Blocks of Life
Combinatorial Chemistry
ORGANIC PHARMACEUTICAL CHEMISTRY IV
D7 Taxol Essential idea Chiral auxiliaries allow the production of individual enantiomers of chiral molecules.
Presentation transcript:

Combinatorial Chemistry Advanced Medicinal Chemistry (Pharm 5219): Section A Ref.: An Introduction to Medicinal Chemistry, 3 rd ed. 2005, G.L.Patrick, Oxford University press Md. Saifuzzaman Assoc. Professor

Combinatorial synthesis A means of producing a large number of compounds in short period of time, using a defined reaction route and a large variety of starting materials and reagents. Combinatorial chemistry is an approach providing efficient synthesis of large collection of molecules & screening of libraries of related compounds to isolate molecule of desirable property.

Combinatorial synthesis Done on a very small scale Using solid phase synthesis Automated or semi-automated process Each reaction in several reaction vessels at the same time and under identical condition, using different reagents in each vessel. When single product is obtained in each vessel – parallel synthesis When mixtures of compounds are produced – mixed synthesis

Why needed? M. chemistry requires – rapid synthesis of large no. of compounds. Major driving force (old)– need to find new lead compounds. At present, an explosion in no. of new drug targets developed by proteomics & genomics. With huge new targets, there is a problem of identifying function of targets and finding lead compounds interacting to them. Driving force (now) – discovery of new drug targets.

Why needed? To find a lead compound – lead discovery program for 100 targets & screen over 1 million compounds per year (avg. works in a pharma company). Com. chem. provides a means of producing that many compounds.

Combinatorial synthesis in drug discovery & drug optimization Find a target Find a lead Isolate active structure Identify structure SAROptimize lead Combinatorial synthesis

How used? Both parallel & mixed syntheses – can be used But mixed synthesis – generate more structure & increase chance of finding a lead compound. Mixtures of compounds – produced in each reaction flask (thousands or even millions of novel structures vs few dozen by conventional means).

How used? Mixtures of compounds in a reaction vessel – tested for biological activity. If negative, no need to study that mixture & stored. If positive, identify which component is active compound. That saves effort of synthesizing, purifying and identifying each components of that mixture.

Mixed combinatorial synthesis: equivalent of nature’s chemical pool Through evolution, nature has produced a huge number & variety of chemical structures, some biologically active. Traditionally, active principles – picked up from that pool and developed. Mixed combinatorial synthesis – pools of purely synthetic structures – pick up active compounds. Diversity is less but isolating, purifying and identifying new agents is faster.

Parallel synthesis in SAR & drug optimization Each compound has to be tested individually. Though more compounds by mixed synthesis, time saved in producing them lost in separation & identification. Parallel synthesis is more common than mixed synthesis in Ph. Industry.

Advantages of Combinatorial Synthesis Perform fewer reactions and fewer tests to identify the biological activity of a “winning” molecule Use synthetic organic chemistry to generate many compounds in a single or parallel batch

Synthesis of Fruity Esters Assigned Problem Use combinatorial chemistry to synthesize an ester of an assigned scent.

CH 3 OHA1 CH 3 CH 2 OHA2 1-pentanolA3 3-methylbutanol A4 1-octanol A5 Butanoic acidC1 Propanoic acidC2 Acetic acidC3 Generation of library of molecules Mix combinations of alcohols and carboxylic acids to solve the assigned problem Possible combinations – A1C1, A1C2, A1C3……. Deconvolution of library – checking the odor of esters

Preparation of Hydrazones and Discovery of an Antibiotic Compound using Combinatorial techniques Synthesis of Hydrazones

A1-B1 A2-B1 A3-B1 A1-B2 A2-B2 A3-B2 A1-B3 A2-B3 A3-B3 Generation of Libraries

Solid phase techniques Combinatorial experiments….. Few - in solution Majority - using solid phase techniques

Solid phase techniques Advantages of solid phase techniques 1.Different starting materials - bound to separate beads – mixed together – treated with another reagent as a single experiment. Starting materials & products – still physically distinct. 2.Excess reagents and unbound by-products – can be removed by washing the resin. 3.Large excesses of reagents – can be used to drive the reactions to completion (≥ 99%). 4.If low loadings (≤ 0.8 mmol/g support), undesired side effects (e.g., cross-linking) can be suppressed.

Solid phase techniques Advantages of solid phase techniques….. 5.Intermediates – bound to the bead, so no need to purify. 6.Individual beads – separated at the end to yield individual products. 7.Polymeric support – regenerated & reused if appropriate cleavage conditions and suitable anchor/linker groups. 8.Automation possible.

Solid phase techniques Essential requirements for solid phase synthesis A cross-linked insoluble polymeric support – inert to reaction conditions (e.g., a resin bead). An anchor/linker covalently linked to resin – with a reactive functional group (i.e., substrates can attach to it). A bond linking substance to linker – stable to reaction conditions used in synthesis. A means of cleaving products or intermediates from linker. Protection of functional groups not involved in synthesis.